CAR
The Central African Republic (CAR) is a landlocked country in Central Africa. It is bordered by Chad to the north, Sudan to the northeast, South Sudan to the east, the Democratic Republic of the Congo to the south, the Republic of the Congo to the southwest, and Cameroon to the west. The CAR covers a land area of about 620,000 square kilometres (240,000 sq mi). As of 2024, it has a population of 5,357,744, consisting of about 80 ethnic groups. Having been a French colony under the name Ubangi-Shari, Sango is its national language and was also its co-official language alongside French. Its capital and largest city is Bangui, which sits on the country's southern border with the Democratic Republic of the Congo.
Beyond's analysis on CAR
- — Avis Budget Group faces critical deadline for lead plaintiff applications in securities fraud class action lawsuit
- — PeproMene Bio validates BAFF-R targeted CAR T-cell therapy in The Lancet with breakthrough results for relapsed B-cell lymphomas
- — Investors with over $100,000 losses in Avis Budget Group must file lead plaintiff claims by Sept 29, 2026 in ongoing securities class action
- — ClaimsFiler reminds Avis Budget Group investors of September 29 lead plaintiff deadline in securities class action
- — Rosen Law Firm alerts Avis Budget Group investors of chance to lead securities fraud class action against Pentwater Capital Management over alleged short‑swing profits
- — Rosen Law Firm invites Avis Budget investors to lead a securities fraud class action against Pentwater Capital Management over alleged short‑squeeze manipulation
- — RiboX Therapeutics secures FDA IND clearance for RXIM002, the world's first circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias, enabling Phase 1 trial initiation
- — Avis Budget Group faces shareholder deadline pressure as securities class action lawsuit advances
- — Pomerantz Law Firm files class action against Avis Budget Group over alleged securities fraud tied to Pentwater Capital Management's trading activity
- — CellOrigin’s reveal of two solid‑tumor CAR‑cell candidates and a Walvax partnership signals accelerated clinical progress and potential commercialization in the competitive immuno‑oncology arena
Recent news mentioning CAR
- — I Giochi della Speranza: a Rebibbia lo sport supera le mura del carcere
- — Napoli-Frosinone, Allegri: "De Bruyne? Da play si allungherebbe la carriera"
- — NARUTO CARD GAME Sets June 2027 Worldwide Launch at New York Comic Con
- — Allegri: "De Bruyne? Da play allungherebbe la carriera"
- — Scarletts-Benetton: highlights URC Rugby
- — Cómo sacar partido a la fiscalidad de la vivienda tras el nuevo decreto
- — Paderborn-Stoccarda 0-2: gol e highlights
- — Pergolettese-Carpi 2-1: gol e highlights
- — Fallo di Diego Carlos su Esposito, interviene il Var: giusto il rigore in Inter-Parma?
- — Las diez innovaciones con las que Decathlon quiere hacer más accesible practicar deporte
- — Alcaraz: "Baffi? Una scommessa con il mio team"
- — Alcaraz: "Ho giocato una partita ottima"